ART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY ROA Market segmentation by RoA Comparison by RoA Oral - Market size and forecast 2018-2023 Parenteral - Market size and forecast 2018-2023 Market opportunity by RoA PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES Market drivers Market challenges PART 11: MARKET TRENDS Increasing research on anticoagulant antidotes Strategic alliances Extensive research on regenerative therapies PART 12: VENDOR LANDSCAPE Overview Landscape disruption Competitive scenario PART 13: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Boehringer Ingelheim International GmbH Bristol-Myers Squibb Co. Daiichi Sankyo Co. Ltd. F. Hoffmann-La Roche Ltd. Johnson & Johnson Services Inc. PART 14: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global pharmaceuticals market Exhibit 02: Segments of global pharmaceuticals market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: RoA - Market share 2018-2023 (%) Exhibit 18: Comparison by RoA Exhibit 19: Oral - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Oral - Year-over-year growth 2019-2023 (%) Exhibit 21: Parenteral - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Parenteral - Year-over-year growth 2019-2023 (%) Exhibit 23: Market opportunity by RoA Exhibit 24: Customer landscape Exhibit 25: Market share by geography 2018-2023 (%) Exhibit 26: Geographic comparison Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 28: North America - Year-over-year growth 2019-2023 (%) Exhibit 29: Top 3 countries in North America Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Europe - Year-over-year growth 2019-2023 (%) Exhibit 32: Top 3 countries in Europe Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: Top 3 countries in Asia Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 37: ROW - Year-over-year growth 2019-2023 (%) Exhibit 38: Top 3 countries in ROW Exhibit 39: Key leading countries Exhibit 40: Market opportunity Exhibit 41: Impact of drivers and challenges Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Boehringer Ingelheim International GmbH - Vendor overview Exhibit 48: Boehringer Ingelheim International GmbH - Business segments Exhibit 49: Boehringer Ingelheim International GmbH - Organizational developments Exhibit 50: Boehringer Ingelheim International GmbH - Geographic focus Exhibit 51: Boehringer Ingelheim International GmbH - Segment focus Exhibit 52: Boehringer Ingelheim International GmbH - Key offerings Exhibit 53: Boehringer Ingelheim International GmbH - Key customers Exhibit 54: Bristol-Myers Squibb Co. - Vendor overview Exhibit 55: Bristol-Myers Squibb Co. - Business segments Exhibit 56: Bristol-Myers Squibb Co. - Organizational developments Exhibit 57: Bristol-Myers Squibb Co. - Geographic focus Exhibit 58: Bristol-Myers Squibb Co. - Key offerings Exhibit 59: Bristol-Myers Squibb Co. - Key customers Exhibit 60: Daiichi Sankyo Co. Ltd. - Vendor overview Exhibit 61: Daiichi Sankyo Co. Ltd. - Business segments Exhibit 62: Daiichi Sankyo Co. Ltd. - Organizational developments Exhibit 63: Daiichi Sankyo Co. Ltd. - Geographic focus Exhibit 64: Daiichi Sankyo Co. Ltd. - Key offerings Exhibit 65: Daiichi Sankyo Co. Ltd. - Key customers Exhibit 66: F. Hoffmann-La Roche Ltd. - Vendor overview Exhibit 67: F. Hoffmann-La Roche Ltd. - Business segments Exhibit 68: F. Hoffmann-La Roche Ltd. - Organizational developments Exhibit 69: F. Hoffmann-La Roche Ltd. - Geographic focus Exhibit 70: F. Hoffmann-La Roche Ltd. - Segment focus Exhibit 71: F. Hoffmann-La Roche Ltd. - Key offerings Exhibit 72: F. Hoffmann-La Roche Ltd. - Key customers Exhibit 73: Johnson & Johnson Services Inc. - Vendor overview Exhibit 74: Johnson & Johnson Services Inc. - Business segments Exhibit 75: Johnson & Johnson Services Inc. - Organizational developments Exhibit 76: Johnson & Johnson Services Inc. - Geographic focus Exhibit 77: Johnson & Johnson Services Inc. - Segment focus Exhibit 78: Johnson & Johnson Services Inc. - Key offerings Exhibit 79: Johnson & Johnson Services Inc. - Key customers Exhibit 80: Validation techniques employed for market sizing Exhibit 81: Definition of market positioning of vendors  

Boehringer Ingelheim International GmbH Bristol-Myers Squibb Co. Daiichi Sankyo Co. Ltd. F. Hoffmann-La Roche Ltd. Johnson & Johnson Services Inc.